Skip to Main Content

Paper Details

Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression.
Oncotarget
18
2016
ABCB1, DMS114, DMS114/, ETAR, FGFR, FGFR1, FGFR1-driven SCLC cell line, FGFR1-driven lung cancer, NFB, NIN cells, NSCLC, NSCLC cell lines, PKC, SCLC, endothelin-A receptor, fibroblast growth factor receptor 1, lung adenocarcinoma, lung cancer, nintedanib, patient, small cell lung cancer, tumor
Author NameAffiliation
Bernhard EnglingerInstitute of Cancer Research, Medical University of Vienna
Stefan KubicekCeMM Research Center for Molecular Medicine of The Austrian Academy of Sciences
  • 1 - 2

Datasets

Release 1.2